Format

Send to

Choose Destination
Mol Oncol. 2016 Mar;10(3):395-407. doi: 10.1016/j.molonc.2015.12.002. Epub 2015 Dec 25.

Challenges in circulating tumor cell detection by the CellSearch system.

Author information

1
Department of Medical Cell BioPhysics, University of Twente, Hallenweg 23, 7522 NH Enschede, The Netherlands.
2
Department of Medical Cell BioPhysics, University of Twente, Hallenweg 23, 7522 NH Enschede, The Netherlands. Electronic address: l.w.m.m.terstappen@utwente.nl.

Abstract

Enumeration and characterization of circulating tumor cells (CTC) hold the promise of a real time liquid biopsy. They are however present in a large background of hematopoietic cells making their isolation technically challenging. In 2004, the CellSearch system was introduced as the first and only FDA cleared method designed for the enumeration of circulating tumor cells in 7.5 mL of blood. Presence of CTC detected by CellSearch is associated with poor prognosis in metastatic carcinomas. CTC remaining in patients after the first cycles of therapy indicates a futile therapy. Here we review challenges faced during the development of the CellSearch system and the difficulties in assigning objects as CTC. The large heterogeneity of CTC and the different approaches introduced in recent years to isolate, enumerate and characterize CTC results in a large variation of the number of CTC reported urging the need for uniform definitions and at least a clear definition of what the criteria are for assigning an object as a CTC.

KEYWORDS:

CellSearch; Circulating tumor cells; Epithelial cell adhesion molecule; Rare event detection

PMID:
26795350
PMCID:
PMC5528971
DOI:
10.1016/j.molonc.2015.12.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center